1. Home
  2. KRNY vs MRVI Comparison

KRNY vs MRVI Comparison

Compare KRNY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNY
  • MRVI
  • Stock Information
  • Founded
  • KRNY 1884
  • MRVI 2014
  • Country
  • KRNY United States
  • MRVI United States
  • Employees
  • KRNY N/A
  • MRVI N/A
  • Industry
  • KRNY Savings Institutions
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNY Finance
  • MRVI Health Care
  • Exchange
  • KRNY Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • KRNY 416.3M
  • MRVI 376.2M
  • IPO Year
  • KRNY 2005
  • MRVI 2020
  • Fundamental
  • Price
  • KRNY $6.39
  • MRVI $3.14
  • Analyst Decision
  • KRNY Buy
  • MRVI Hold
  • Analyst Count
  • KRNY 2
  • MRVI 9
  • Target Price
  • KRNY $7.75
  • MRVI $4.54
  • AVG Volume (30 Days)
  • KRNY 395.0K
  • MRVI 1.7M
  • Earning Date
  • KRNY 10-23-2025
  • MRVI 11-06-2025
  • Dividend Yield
  • KRNY 6.84%
  • MRVI N/A
  • EPS Growth
  • KRNY N/A
  • MRVI N/A
  • EPS
  • KRNY 0.47
  • MRVI N/A
  • Revenue
  • KRNY $158,298,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • KRNY $14.22
  • MRVI N/A
  • Revenue Next Year
  • KRNY N/A
  • MRVI $7.27
  • P/E Ratio
  • KRNY $13.59
  • MRVI N/A
  • Revenue Growth
  • KRNY 23.27
  • MRVI N/A
  • 52 Week Low
  • KRNY $5.45
  • MRVI $1.67
  • 52 Week High
  • KRNY $8.59
  • MRVI $8.29
  • Technical
  • Relative Strength Index (RSI)
  • KRNY 42.18
  • MRVI 48.93
  • Support Level
  • KRNY $6.41
  • MRVI $3.01
  • Resistance Level
  • KRNY $6.65
  • MRVI $3.55
  • Average True Range (ATR)
  • KRNY 0.18
  • MRVI 0.19
  • MACD
  • KRNY -0.03
  • MRVI -0.06
  • Stochastic Oscillator
  • KRNY 9.84
  • MRVI 20.31

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: